Stroke is a major contributor to death and disability worldwide. Prior to modern therapy, post-
stroke mortality was approximately 10% in the acute period, with nearly one-half of the …

Stroke is a leading cause of death and long-term disabilities. Despite decades of extensive
efforts in search of brain injury mechanisms and therapeutic interventions, pharmacological …

Stroke is the second highest cause of death globally and a leading cause of disability, with
an increasing incidence in developing countries. Ischaemic stroke caused by arterial …

Thrombolysis and mechanical thrombectomy have revolutionized the care of patients with
acute ischemic stroke. The number of patients who can benefit from these treatments …

Rapid, safe and effective arterial recanalisation to restore blood flow and improve functional
outcome remains the primary goal of hyperacute ischaemic stroke management. The benefit …

The evolving knowledge on stroke in conjunction with advances in the field of imaging,
treatment approaches using recombinant tissue plasminogen activator (rtPA) or …

Importance Endovascular intervention for acute ischemic stroke improves revascularization.
But trials examining endovascular therapy yielded variable functional outcomes, and the …

Key Clinical Points Acute Ischemic Stroke Treatment for patients with acute ischemic stroke
is guided by the time from the onset of stroke, the severity of neurologic deficit, and findings …

Acute ischaemic stroke is a major public health priority and will become increasingly
relevant to neurologists of the future. The cornerstone of effective stroke care continues to be …

Stroke is a leading cause of morbidity and mortality in the United States. Whether
hemorrhagic or ischemic, stroke leads to severe long-term disability. Prior to the mid-1990s …